Sanofi Scraps $755M Licensing Deal Amid FTC Challenge
Sanofi said Monday it will terminate a planned licensing agreement with Maze Therapeutics after the Federal Trade Commission moved to block the $755 million deal over concerns about a potential competitor...To view the full article, register now.
Already a subscriber? Click here to view full article